Profit jumps 29% to Rs 325 crore signals strong Q2 earnings growth.
Context
What happened: Emcure Pharmaceuticals reported a 29 percent rise in Q2 profit to Rs 325 crore, up from Rs 251.37 crore a year earlier, according to a regulatory filing.
Key numbers: Profit Rs 325 crore vs Rs 251.37 crore. Revenue Rs 2,820.47 crore vs Rs 2,269.82 crore. Total expenses Rs 2,377.87 crore vs Rs 1,931.52 crore. International business up 34 percent to Rs 1,665.2 crore.
Why it matters: Chairman, Managing Director and CEO Satish Mehta said Q2 showed broad-based growth in revenue, profitability and earnings, and that the company expects business momentum to sustain into H2FY27.
What changed
Emcure Pharmaceuticals reported a 29 percent rise in Q2 profit to Rs 325 crore, up from Rs 251.37 crore a year earlier, according to a regulatory filing.
Why it matters
Chairman, Managing Director and CEO Satish Mehta said Q2 showed broad-based growth in revenue, profitability and earnings, and that the company expects business momentum to sustain into H2FY27.